Blueprint Medicines (BPMC) Return on Assets ROA from the first quarter of 2025 to first quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Blueprint Medicines Corporation  (NASDAQ: BPMC)


Blueprint Medicines's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Blueprint Medicines's ROA in the first quarter of 2025?
Blueprint Medicines Corporation recorded a cumulative net loss of $-156 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -13.69%.

However, within the Healthcare sector 318 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 3429, from total ROA ranking in the fourth quarter of 2024 at 3628.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Total Assets Change 24.64 % 14.24 % 9.96 % 9.89 % -15.65 %
Y / Y Net Income Change -99.44 % - - - -
Net Income (TTM) in million -156 -67 -128 -205 -288
Return On Assets (TTM) -13.69 % -6.22 % -12.26 % -20.17 % -29.01 %
BPMC's Total Ranking # 3429 # 3628 # 3453 # 3690 # 3929
Total Assets (TTM) in million 1,196 1,106 1,124 1,127 959
Seq. Total Assets Change 8.13 % -1.62 % -0.24 % 17.44 % -0.89 %
Seq. Net Income Change - - - - -

BPMC's 5 Years Annual ROA >> Back to BPMC Management Effectiveness >> Compare BPMC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 116
Sector # 319
Overall # 3381

Return On Assets Statistics
High Average Low
33.35 %
-30.53 %
-56.88 %
(Sep 30 2020)   (Sep 30 2022)





Financial Statements
Blueprint Medicines's Assets $ 1,196 million BPMC's Balance sheet
Blueprint Medicines's Income $ 0 million Quarterly BPMC's Income Statement
BPMC's Income by Division See BPMC's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change 14.24 % -23.46 % 9.17 % -29.71 % 132.84 %
Total Assets in million 1,106 968 1,264 1,158 1,648
Y / Y Net Income Change - - - - -
Net Income in million -67 -507 -558 -644 314
Annual Return On Assets -6.07 % -52.38 % -44.09 % -55.61 % 19.05 %

BPMC's 5 Years Annual ROA >> Back to BPMC Management Effectiveness >> Compare BPMC ROA to its Competitors



More Return On Assets Ratios
BPMC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BPMC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BPMC's Competitors
Subscribers only: Roa for Blueprint Medicines's Suppliers
Subscribers only: Return On Assets for BPMC's Customers

You may also want to know
BPMC's Roi BPMC's Inventory Turnover Ratio BPMC's Growth Rates BPMC's Dividend Comparisons
BPMC's Profitability Ratios BPMC's Asset Turnover Ratio BPMC's Dividend Growth
BPMC's Roe BPMC's Valuation Ratios BPMC's Financial Strength Ratios BPMC's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA

Date modified: 2026-09-08T16:52:23+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.